Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 25, 2015 2:56 PM ET

Healthcare Equipment and Supplies

Company Overview of LifeScan, Inc.

Company Overview

LifeScan, Inc. develops, manufactures, and sells blood glucose monitoring systems for home and hospital use in the United States and internationally. The company provides glucose monitoring products for people with diabetes, point-of-care institutions, and hospitals. It offers blood glucose meters, test strips, lancing devices, and diabetes management software solutions; and hospital meters, data management systems, glucose control solutions, and linearity test kits. The company also provides pre-installation project management, installation, and post installation support services, including on-site and on-line training programs. It offers products through authorized distributors, including ...

1000 Gibraltar Drive

Milpitas, CA 95035

United States

Founded in 1981





Key Executives for LifeScan, Inc.

Director of Global Education and Professional Relations
Vice President of Strategic Customer Group and Advanced Care Group
Vice President of Worldwide Medical Safety and External Affairs
Director of Marketing
Age: 40
Compensation as of Fiscal Year 2014.

LifeScan, Inc. Key Developments

Decision Diagnostics Rejects Settlement Offers from J&J/Lifescan

Decision Diagnostics Corp. announced that despite repeated refusal of Lifescan's mediation overtures, the company was ordered to attend a mandatory, court-directed mediation on January 29, 2015. Following two separate days of these compulsory discussions at the Federal District Court for Northern California (San Francisco), which concluded on February 23, 2015 the company has again rejected Lifescan's settlement offers. The company, more importantly, is announcing that the preparation for an expected explosion of product demand following legal victory has already begun. Solicitations for interview and quotation have been circulated to various internationally certified and FDA approved manufacturers for the contract manufacture of GenStrip™ 50. The time frame for tooling creation, first article part delivery and full product production is expected to fall within a five to seven month timeframe, following the final selection of an international contract manufacturer. Concurrent to the fulfillment of supplemental GenStrip™ 50 manufacturing, that selected manufacturer will simultaneously be charged with the completion of a new product that has been under internal development for nearly a year. Several of these manufacturing candidates are currently manufacturing second generation, FDA cleared, embryonic versions of the company's (3rd generation) product concept.

LifeScan, Inc. Introduces New OneTouch Verio Blood Glucose Monitoring System

LifeScan, Inc. has introduced the new OneTouch Verio Blood Glucose Monitoring System that helps people with diabetes better understand their results without any extra effort. Easy to use, the OneTouch Verio System features a color-coded range indicator that shows whether a test result is within, below or above the range limits set in the meter without the need to scroll or push buttons. It also looks for signs of progress and provides positive reinforcement with Progress Notes, which inform patients about the progress they are making in managing their diabetes and how often their blood glucose results are in range. After using the OneTouch Verio Meter for a week, 94% of people with diabetes said it made their test results simple to understand. The low and high range limits set in the OneTouch Verio Meter can be customized for each patient based on their healthcare professional's recommendations. With each test, the color-coded range indicator feature shows whether a result is below limit (blue), within range (green) or above the limit (red). When the meter displays a low result, it prompts the user to treat the low glucose result and retest in 15 minutes. OneTouch Verio Meter Key Features: Simple testing, color-coded range indicator, progress notes, automatic 7-day averages, high-resolution color display with large on-screen results, and accurate results.

UniStrip Technologies, LLC Sues LifeScan, Inc. for Antitrust Violations

UniStrip Technologies, LLC has filed an antitrust lawsuit in the Los Angeles federal court against LifeScan, Inc. for violations of the Sherman and Clayton Acts. UniStrip alleges in its complaint, LifeScan has taken anti-competitive measures by withholding rebates, cooperative marketing funds, and other incentives from wholesalers and retailers who offer UniStrip1 for sale. LifeScan's attempts to preclude UniStrip's entry into the market were coordinated within the company, executed by sales representatives, and added to contracts that expressly conditioned the payment of rebates for LifeScan products on the distributor's refusal to purchase and sell UniStrip products.

Similar Private Companies By Industry

Company Name Region
Epinex Diagnostics, Inc. United States
Sorbx, LLC United States
Ir2dx, Inc. United States
Micro Interventional Devices, Inc. United States
Diazyme Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LifeScan, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at